We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+21.69%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$150M
AUM Growth
+$13M
(+9.5%)
Cap. Flow
-$2.13M
Cap. Flow
% of AUM
-1.42%
Top 10 Holdings %
Top 10 Hldgs %
33.6%
Holding
92
New
24
Increased
18
Reduced
19
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Martin Marietta Materials
MLM
|
+$3.6M |
| 2 |
Icon
ICLR
|
+$3.13M |
| 3 |
Edwards Lifesciences
EW
|
+$3.1M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$3.06M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$2.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.76M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
+$2.87M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$2.47M |
| 4 |
AGN
Allergan Inc
AGN
|
+$2.4M |
| 5 |
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
|
+$2.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.29% |
| 2 | Industrials | 15.71% |
| 3 | Communication Services | 12.16% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Materials | 2.61% |
Similar funds
AGA
ATS
RIM
ACM
CAM
LSA
GWA
Atika Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Atika Capital Management held 92 positions worth $150M, up 9.5% from $137M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Atika Capital Management's Q1 2015 filing shows 24 new, 18 increased, 19 reduced and 31 closed positions. Its largest new stake was Martin Marietta Materials: 28,000 shares worth $3.92M. The largest sale was AbbVie, an estimated $3.76M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Industrials and Communication Services.
- Atika Capital Management's largest Q1 2015 buy was Martin Marietta Materials: 28,000 shares worth $3.92M.
- Atika Capital Management added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q1 2015, an estimated $1.63M increase.
- Atika Capital Management's biggest Q1 2015 reduction was Acadia Pharmaceuticals, cutting an estimated $2.87M.
- Atika Capital Management fully exited AbbVie in Q1 2015, selling an estimated $3.76M.
- Atika Capital Management's ten largest holdings make up 34% of its $150M portfolio in Q1 2015.
- Atika Capital Management opened 24 new positions and closed 31 in Q1 2015.
- Atika Capital Management's portfolio value rose 9.5% quarter-over-quarter to $150M.
Based on Atika Capital Management's 13F filing for Q1 2015, filed 15 May 2015.